Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 71676 - 71700 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	MMRN2	79812	upregulated	Silicon Dioxide results in increased expression of MMRN2 mRNA	10q23.2	A24196
Silicon dioxide	Approved	MN1	4330	upregulated	Silicon Dioxide analog results in increased expression of MN1 mRNA	22q12.1	A24195
Silicon dioxide	Approved	MNS1	55329	downregulated	Silicon Dioxide analog results in decreased expression of MNS1 mRNA	15q21.3	A24195
Silicon dioxide	Approved	MOB3B	79817	upregulated	Silicon Dioxide analog results in increased expression of MOB3B mRNA	9p21.2	A24195
Silicon dioxide	Approved	MOB3C	148932	upregulated	Silicon Dioxide analog results in increased expression of MOB3C mRNA	1p33	A24195
Silicon dioxide	Approved	MOBP	4336	upregulated	Silicon Dioxide analog results in increased expression of MOBP mRNA	3p22.1	A24194
Silicon dioxide	Approved	MOCOS	55034	downregulated	Silicon Dioxide results in decreased expression of MOCOS mRNA	18q12.2	A24196
Silicon dioxide	Approved	MOK	5891	upregulated	Silicon Dioxide analog results in increased expression of MOK mRNA	14q32.31	A24195
Silicon dioxide	Approved	MORN5	254956	downregulated	Silicon Dioxide analog results in decreased expression of MORN5 mRNA	9q33.2	A24195
Silicon dioxide	Approved	MOSPD1	56180	upregulated	Silicon Dioxide analog results in increased expression of MOSPD1 mRNA	Xq26.3	A24195
Silicon dioxide	Approved	MOSPD3	64598	downregulated	Silicon Dioxide analog results in decreased expression of MOSPD3 mRNA	7q22.1	A24195
Silicon dioxide	Approved	MPHOSPH6	10200	upregulated	Silicon Dioxide analog results in increased expression of MPHOSPH6 mRNA	16q23.3	A24195
Silicon dioxide	Approved	MPHOSPH9	10198	downregulated	Silicon Dioxide results in decreased expression of MPHOSPH9 mRNA	12q24.31	A24196
Silicon dioxide	Approved	MPIG6B	80739	upregulated	Silicon Dioxide analog results in increased expression of MPIG6B mRNA	6p21.33	A24195
Silicon dioxide	Approved	MPP1	4354	upregulated	Silicon Dioxide analog results in increased expression of MPP1 mRNA	Xq28	A24195
Silicon dioxide	Approved	MPP3	4356	upregulated	Silicon Dioxide analog results in increased expression of MPP3 mRNA	17q21.31	A24195
Silicon dioxide	Approved	MPP4	58538	upregulated	Silicon Dioxide analog results in increased expression of MPP4 mRNA	2q33.1	A24195
Silicon dioxide	Approved	MPPE1	65258	downregulated	Silicon Dioxide results in decreased expression of MPPE1 mRNA	18p11.21	A24196
Silicon dioxide	Approved	MPV17L	255027	upregulated	Silicon Dioxide analog results in increased expression of MPV17L mRNA	16p13.11	A24195
Silicon dioxide	Approved	MPZL3	196264	downregulated	Silicon Dioxide analog results in decreased expression of MPZL3 mRNA	11q23.3	A24195
Silicon dioxide	Approved	MR1	3140	downregulated	Silicon Dioxide analog results in decreased expression of MR1 mRNA	1q25.3	A24195
Silicon dioxide	Approved	MRAP2	112609	downregulated	Silicon Dioxide analog results in decreased expression of MRAP2 mRNA	6q14.2	A24195
Silicon dioxide	Approved	MRC1	4360	upregulated	Silicon Dioxide analog results in increased expression of MRC1 mRNA	10p12.33	A24194
Silicon dioxide	Approved	MRGPRE	116534	upregulated	Silicon Dioxide analog results in increased expression of MRGPRE mRNA	11p15.4	A24195
Silicon dioxide	Approved	MRNIP	51149	upregulated	Silicon Dioxide results in increased expression of MRNIP mRNA	5q35.3	A24196

Displaying entries 71676 - 71700 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability